Stingeni, L.; Ravasio, R.; Palladino, C.; Di Fino, S.; Levi, A.; Ronci, G.; Gisondi, P. Cost Per Responder of Upadacitinib 30 Mg and Dupilumab 300 Mg in Patients With Moderate-to-Severe Atopic Dermatitis in Italy. Grhta 2025, 12, 70-79.